Φορτώνει......
Novel EGFR-targeted strategy with hybrid peptide against oesophageal squamous cell carcinoma
Epidermal growth factor receptor (EGFR) is a key molecule in the pathophysiology of oesophageal squamous cell carcinoma (OSCC). However, EGFR-targeted agents such as anti-EGFR antibody or tyrosine kinase inhibitors for OSCC have not demonstrated any clinical benefits. Recently, a novel chemotherapeu...
Αποθηκεύτηκε σε:
Τόπος έκδοσης: | Sci Rep |
---|---|
Κύριοι συγγραφείς: | , , , , , , , , |
Μορφή: | Artigo |
Γλώσσα: | Inglês |
Έκδοση: |
Nature Publishing Group
2016
|
Θέματα: | |
Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4796678/ https://ncbi.nlm.nih.gov/pubmed/26956916 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep22452 |
Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|